Drug information for AGENERASE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 150MG Discontinued   AMPRENAVIR amprenavir GLAXOSMITHKLINE 21007
2005-11-18 Letter

2005-11-16 Label

2004-05-26 Review

2004-05-26 Review

2004-04-05 Label

2004-03-02 Letter

2002-10-02 Letter

2002-10-02 Label

2002-10-02 Letter

2002-10-02 Label

2002-08-02 Letter

2002-08-02 Label

2002-02-05 Letter

2002-02-05 Letter

2001-05-11 Letter

2001-05-11 Label

1999-04-15 Letter

1999-04-15 Label
CAPSULE; ORAL 50MG Discontinued   AMPRENAVIR amprenavir GLAXOSMITHKLINE   "
SOLUTION; ORAL 15MG/ML **Federal Register notice determination that product was not discontinued or withdrawn for safety or efficacy reasons** Discontinued   AMPRENAVIR amprenavir GLAXOSMITHKLINE 21039
2005-11-18 Letter

2005-11-08 Label

2004-05-26 Review

2004-05-26 Review

2004-04-05 Label

2004-03-02 Letter

2002-10-02 Letter

2002-10-02 Label

2002-10-02 Letter

2002-10-02 Label

2002-08-02 Letter

2002-08-02 Label

2002-02-05 Letter

2002-02-05 Letter

2001-05-11 Letter

2001-05-11 Label

1999-04-15 Letter

1999-04-15 Label
Ads by Google